Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
The Evolution of Medical Communications: How to Get the Most Out of Standard Response Documents
Better patient awareness has led to a rapid increase in the number of MI requests...
Ways Pharma Showed Patients How They Matter
Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...
From Transactional to Transformational: Bringing Patient Centricity to the Next Level
The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Leveraging Technology to Enhance Customer Experience – A 3-Pronged Approach for Medical Affairs
As digital technology changes everything from how drugs are discovered to how healthcare is delivered...
Reimagining the MSL-KOL Relationship
MSL-KOL relationships: Medical Affairs teams and KOLs believe that approximately 40-50% of future interactions will...